Cardiovascular disease in diabetic women without cardiac symptoms;Doença cardiovascular em mulheres diabéticas assintomáticas

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 51, Issue 2, 2007, Pages 305-311

  Smanio, Paola ^a,b  

^a Fleury   (Brazil)

^b Seção de Medicina Nuclear   (Brazil)

Author keywords

Coronary artery disease; Diabetes mellitus; Diagnosis; Women

Indexed keywords

EID: 34248573687     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/s0004-27302007000200021     Document Type: Review

References (42)

1. Consensus development conference on the diagnosis of coronary heart disease in people with diabetes: 10-11 February 1998, Miami, Florida. American Diabetes Association. Diabetes Care 1998;21:1551-9.
2. ADA Clinical Practice Recommendations. Diabetes Care 2003;26(suppl 1):S1-156.
3. Alexander CM, Landsman PB, Teutsch SM. Diabetes mellitus, impaired fasting glucose, atherosclerotic risk factors, and prevalence of coronary heart disease. Am J Cardiol 2000;86:897-902.
4. American Diabetes Association. Consensus Development Conference on the Diagnosis of Coronary Artery Disease in People with Diabetes. 1998. p. 1551.
5. Kannel WB. The Framingham Study: historical insight on the impact of cardiovascular risk factors in men versus women. J Gend Specif Med 2002;5:27-37.
6. Secretaria da Saúde do Estado de São Paulo. SEADE. Disponível em: 〈http://www.saude.gov.br〉. Acessado em 2001.
7. Di Carli MF, Hachamovitch R. Should we screen for occult coronary artery disease among asymptomatic patients with diabetes? J Am Coll Cardiol 2005;45:50-3.
8. Sociedade Brasileira de Diabetes. Consenso Brasileiro de Diabetes, 2002. Diagnóstico e classificação do diabetes melito e tratamento do diabetes melito do tipo 2. Rio de Janeiro: Diagraphic, 2003.
9. Langer A, Freeman MR, Josse RG, Steiner G, Armstrong PW. Detection of silent myocardial ischemia in diabetes mellitus. Am J Cardiol 1991;67:1073-8.
10. Mieres JH, Shaw LJ, Hendel RC, Miller DD, Bonow RO, Berman DS, et al. American Society of Nuclear Cardiology consensus statement: Task Force on Women and Coronary Artery Disease - the role of myocardial perfusion imaging in the clinical evaluation of coronary artery disease in women. J Nucl Cardiol 2003;10:95-101.
11. Pan WH, Cedres LB, Liu K, Dyer A, Schoenberger JA, Shekelle RB, et al. Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol 1986;123:504-16.
12. American Heart Association. American Heart Association: 2000 Heart and Stroke Statistical Update. Dallas, TX, 1999.
13. Andrade J, Brito FS, Vilas-Boas F, Castro I, Oliveira JA, Guimarães JI, et al. II Diretrizes da Sociedade Brasileira de Cardiologia sobre Teste Ergométrico. Arq Bras Cardiol 2002;78:1-42.
14. Schlant RC, Blomqvist CG, Brandenburg RO, DeBusk R, Ellestad MH, Fletcher GF, et al. Guidelines for exercise testing. A report of the Joint American College of Cardiology/American Heart Association Task Force on Assessment of Cardiovascular Procedures (Subcommittee on Exercise Testing). Circulation 1986;74:653A-67.
15. Pollock ML, Franklin BA, Balady GJ, Chaitman BL, Fleg JL, Fletcher B, et al. AHA Science Advisory. Resistance exercise in individuals with and without cardiovascular disease: benefits, rationale, safety, and prescription: An advisory from the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiology, American Heart Association; Position paper endorsed by the American College of Sports Medicine. Circulation 2000;101:828-33.
16. Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). Circulation 2003;108:1404-18.
17. Mosca L, Appel LJ, Benjamin EJ, Berra K, Chandra-Strobos N, Fabunmi RP, et al. Evidence-based guidelines for cardiovascular disease prevention in women. American Heart Association Scientific Statement. Arteriosclerosis Thromb Vasc Biol 2004;24:e29-50.
18. Shaw LJ, Heller GV, Travin MI, Lauer M, Marwick T, Hachamovitch R, et al. Cost analysis of diagnostic testing for coronary artery disease in women with stable chest pain. Economics of Noninvasive Diagnosis (END) Study Group. J Nucl Cardiol 1999;6:559-69.
19. Shaw LJ, Miller DD, Romeis JC, Kargl D, Younis LT, Chaitman BR. Gender differences in the noninvasive evaluation and management of patients with suspected coronary artery disease. Ann Intern Med 1994;120:559-66.
20. Douglas PS, Ginsburg GS. The evaluation of chest pain in women. N Engl J Med 1996;334:1311-5.
21. Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 1986;111:383-90.
22. Kannel WB, Wilson PW, D'Agostino RB, Cobb J. Sudden coronary death in women. Am Heart J 1998;136:205-12.
23. Mosca L, Grundy SM, Judelson D, King K, Limacher M, Oparil S, et al. Guide to Preventive Cardiology for Women. AHA/ACC Scientific Statement Consensus panel statement. Circulation 1999;99:2480-4.
24. Fisher LD, Kennedy JW, Chaitman BR, Ryan TJ, McCabe C, Weiner D, et al. Diagnostic quantification of CASS (coronary artery surgery study) clinical and exercise test results in determining presence and extent of coronary artery disease. A multivariate approach. Circulation 1981;63:987-1000.
25. Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ, et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 2004;27:1954-61.
26. San Roman JA, Vilacosta I, Castillo JA, Rollan MJ, Hernandez M, Peral V, et al. Selection of the optimal stress test for the diagnosis of coronary artery disease. Heart 1998;80:370-6.
27. Henzlova MJ, Croft LB, Diamond JA. Effect of hormone replacement therapy on the electrocardiographic response to exercise. J Nucl Cardiol 2002;9:385-7.
28. Mastrocolla LE. Consenso nacional de ergometria. Arq Bras Cardiol 1995;2:211.
29. Barolsky SM, Gilbert CA, Faruqui A, Nutter DO, Schlant RC. Differences in electrocardiographic response to exercise of women and men: a non-Bayesian factor. Circulation 1979;60:1021-7.
30. Kwok Y, Kim C, Grady D, Segal M, Redberg R. Meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol 1999;83:660-6.
31. Hlatky MA, Pryor DB, Harrell Jr. FE, Califf RM, Mark DB, Rosati RA. Factors affecting sensitivity and specificity of exercise electrocardiography. Multivariable analysis. Am J Med 1984;77:64-71.
32. Robert AR, Melin JA, Detry JM. Logistic discriminant analysis improves diagnostic accuracy of exercise testing for coronary artery disease in women. Circulation 1991;83:1202-9.
33. Gould KL, Lipscomb K. Effects of coronary stenoses on coronary flow reserve and resistance. Am J Cardiol 1974;34:48-55.
34. Leppo JA. Dipyridamole-thallium imaging: the lazy man's stress test. J Nucl Med 1989;30:281-7.
35. Daou D, Delahaye N, Vilain D, Lebtahi R, Faraggi M, Le GD. Identification of extensive coronary artery disease: incremental value of exercise Tl-201 SPECT to clinical and stress test variables. J Nucl Cardiol 2002;9:161-8.
36. Smanio PE, Watson DD, Segalla DL, Vinson EL, Smith WH, Beller GA. Value of gating of technetium-99m sestamibi single-photon emission computed tomographic imaging. J Am Coll Cardiol 1997;30:1687-92.
37. Taillefer R, DePuey EG, Udelson JE, Beller GA, Latour Y, Reeves F. Comparative diagnostic accuracy of Tl-201 and Tc-99m sestamibi SPECT imaging (perfusion and ECG-gated SPECT) in detecting coronary artery disease in women. J Am Coll Cardiol 1997;29:69-77.
38. Borges-Neto S, Mahmarian JJ, Jain A, Roberts R, Verani MS. Quantitative thallium-201 single photon emission computed tomography after oral dipyridamole for assessing the presence, anatomic location and severity of coronary artery disease. J Am Coll Cardiol 1988;11:962-9.
39. Tebexreni AS, Smanio PE. Myocardial scintigraphy for the assessment of perfusion in diabetic patients. Arq Bras Endocrinol Metab 2004;48:329-30.
40. Becker LC. Conditions for vasodilator-induced coronary steal in experimental myocardial ischemia. Circulation 1978;57:1103-10.
41. Mahmarian JJ, Verani MS. Myocardial perfusion imaging during pharmacologic stress testing. Cardiol Clin 1994;12:223-45.
42. Lette J, Tatum JL, Fraser S, Miller DD, Waters DD, Heller G, et al. Safety of dipyridamole testing in 73,806 patients: the Multicenter Dipyridamole Safety Study. J Nucl Cardiol 1995;2:3-17.